crus-20250927
false
2026
Q2
3/28
0000772406
P1Y
457
367
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
crus:derivativeContract
crus:segment
crus:product_line
0000772406
2025-03-30
2025-09-27
0000772406
2025-10-31
0000772406
2025-09-27
0000772406
2025-03-29
0000772406
2025-06-29
2025-09-27
0000772406
2024-06-30
2024-09-28
0000772406
2024-03-31
2024-09-28
0000772406
2024-03-30
0000772406
2024-09-28
0000772406
us-gaap:CommonStockMember
2024-06-29
0000772406
us-gaap:AdditionalPaidInCapitalMember
2024-06-29
0000772406
us-gaap:RetainedEarningsMember
2024-06-29
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-29
0000772406
2024-06-29
0000772406
us-gaap:RetainedEarningsMember
2024-06-30
2024-09-28
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
2024-09-28
0000772406
us-gaap:CommonStockMember
2024-06-30
2024-09-28
0000772406
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
2024-09-28
0000772406
us-gaap:CommonStockMember
2024-09-28
0000772406
us-gaap:AdditionalPaidInCapitalMember
2024-09-28
0000772406
us-gaap:RetainedEarningsMember
2024-09-28
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-28
0000772406
us-gaap:CommonStockMember
2025-06-28
0000772406
us-gaap:AdditionalPaidInCapitalMember
2025-06-28
0000772406
us-gaap:RetainedEarningsMember
2025-06-28
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-28
0000772406
2025-06-28
0000772406
us-gaap:RetainedEarningsMember
2025-06-29
2025-09-27
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-29
2025-09-27
0000772406
us-gaap:CommonStockMember
2025-06-29
2025-09-27
0000772406
us-gaap:AdditionalPaidInCapitalMember
2025-06-29
2025-09-27
0000772406
us-gaap:CommonStockMember
2025-09-27
0000772406
us-gaap:AdditionalPaidInCapitalMember
2025-09-27
0000772406
us-gaap:RetainedEarningsMember
2025-09-27
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-27
0000772406
us-gaap:CommonStockMember
2024-03-30
0000772406
us-gaap:AdditionalPaidInCapitalMember
2024-03-30
0000772406
us-gaap:RetainedEarningsMember
2024-03-30
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-30
0000772406
us-gaap:RetainedEarningsMember
2024-03-31
2024-09-28
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-31
2024-09-28
0000772406
us-gaap:CommonStockMember
2024-03-31
2024-09-28
0000772406
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
2024-09-28
0000772406
us-gaap:CommonStockMember
2025-03-29
0000772406
us-gaap:AdditionalPaidInCapitalMember
2025-03-29
0000772406
us-gaap:RetainedEarningsMember
2025-03-29
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-29
0000772406
us-gaap:RetainedEarningsMember
2025-03-30
2025-09-27
0000772406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-30
2025-09-27
0000772406
us-gaap:CommonStockMember
2025-03-30
2025-09-27
0000772406
us-gaap:AdditionalPaidInCapitalMember
2025-03-30
2025-09-27
0000772406
us-gaap:DomesticCorporateDebtSecuritiesMember
2025-09-27
0000772406
us-gaap:USTreasurySecuritiesMember
2025-09-27
0000772406
srt:MinimumMember
2025-03-30
2025-09-27
0000772406
srt:MaximumMember
2025-03-30
2025-09-27
0000772406
us-gaap:DomesticCorporateDebtSecuritiesMember
2025-03-29
0000772406
us-gaap:USTreasurySecuritiesMember
2025-03-29
0000772406
us-gaap:RevolvingCreditFacilityMember
us-gaap:SecuredOvernightFinancingRateSofrMember
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2023-03-20
2023-03-20
0000772406
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
2025-09-27
0000772406
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2025-09-27
0000772406
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
2025-09-27
0000772406
us-gaap:MoneyMarketFundsMember
2025-09-27
0000772406
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-09-27
0000772406
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-09-27
0000772406
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-09-27
0000772406
us-gaap:CorporateDebtSecuritiesMember
2025-09-27
0000772406
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-09-27
0000772406
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-09-27
0000772406
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-09-27
0000772406
us-gaap:FairValueInputsLevel1Member
2025-09-27
0000772406
us-gaap:FairValueInputsLevel2Member
2025-09-27
0000772406
us-gaap:FairValueInputsLevel3Member
2025-09-27
0000772406
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
2025-03-29
0000772406
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2025-03-29
0000772406
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
2025-03-29
0000772406
us-gaap:MoneyMarketFundsMember
2025-03-29
0000772406
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-03-29
0000772406
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-03-29
0000772406
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-03-29
0000772406
us-gaap:CorporateDebtSecuritiesMember
2025-03-29
0000772406
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-03-29
0000772406
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-03-29
0000772406
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-03-29
0000772406
us-gaap:FairValueInputsLevel1Member
2025-03-29
0000772406
us-gaap:FairValueInputsLevel2Member
2025-03-29
0000772406
us-gaap:FairValueInputsLevel3Member
2025-03-29
0000772406
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2025-06-29
2025-09-27
0000772406
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2024-06-30
2024-09-28
0000772406
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2025-03-30
2025-09-27
0000772406
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2024-03-31
2024-09-28
0000772406
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
2021-07-08
0000772406
us-gaap:RevolvingCreditFacilityMember
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
crus:VariableRateComponentTwoMember
srt:MinimumMember
us-gaap:LineOfCreditMember
2023-03-20
2023-03-20
0000772406
us-gaap:RevolvingCreditFacilityMember
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
crus:VariableRateComponentTwoMember
srt:MaximumMember
us-gaap:LineOfCreditMember
2023-03-20
2023-03-20
0000772406
us-gaap:RevolvingCreditFacilityMember
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
us-gaap:SecuredOvernightFinancingRateSofrMember
srt:MinimumMember
us-gaap:LineOfCreditMember
2023-03-20
2023-03-20
0000772406
us-gaap:RevolvingCreditFacilityMember
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
us-gaap:SecuredOvernightFinancingRateSofrMember
srt:MaximumMember
us-gaap:LineOfCreditMember
2023-03-20
2023-03-20
0000772406
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
srt:MinimumMember
2023-03-20
2023-03-20
0000772406
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
srt:MaximumMember
2023-03-20
2023-03-20
0000772406
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
2023-03-20
0000772406
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
2023-03-20
2023-03-20
0000772406
crus:SecondAmendedCreditAgreementRevolvingCreditFacilityMember
2025-09-27
0000772406
crus:AudioProductsSegmentMember
2025-06-29
2025-09-27
0000772406
crus:AudioProductsSegmentMember
2024-06-30
2024-09-28
0000772406
crus:AudioProductsSegmentMember
2025-03-30
2025-09-27
0000772406
crus:AudioProductsSegmentMember
2024-03-31
2024-09-28
0000772406
crus:HighPerformanceMixedSignalProductsMember
2025-06-29
2025-09-27
0000772406
crus:HighPerformanceMixedSignalProductsMember
2024-06-30
2024-09-28
0000772406
crus:HighPerformanceMixedSignalProductsMember
2025-03-30
2025-09-27
0000772406
crus:HighPerformanceMixedSignalProductsMember
2024-03-31
2024-09-28
0000772406
country:CN
2025-06-29
2025-09-27
0000772406
country:CN
2024-06-30
2024-09-28
0000772406
country:CN
2025-03-30
2025-09-27
0000772406
country:CN
2024-03-31
2024-09-28
0000772406
country:US
2025-06-29
2025-09-27
0000772406
country:US
2024-06-30
2024-09-28
0000772406
country:US
2025-03-30
2025-09-27
0000772406
country:US
2024-03-31
2024-09-28
0000772406
crus:OtherCountriesMember
2025-06-29
2025-09-27
0000772406
crus:OtherCountriesMember
2024-06-30
2024-09-28
0000772406
crus:OtherCountriesMember
2025-03-30
2025-09-27
0000772406
crus:OtherCountriesMember
2024-03-31
2024-09-28
0000772406
2021-07-28
2021-07-28
0000772406
crus:July2022RepurchaseProgramMember
2022-07-31
0000772406
crus:A2025RepurchaseProgramMember
2025-03-31
0000772406
crus:A2025RepurchaseProgramMember
2025-03-31
2025-09-27
0000772406
crus:A2025RepurchaseProgramMember
2025-09-27
0000772406
crus:A2025RepurchaseProgramMember
2025-06-29
2025-09-27
0000772406
crus:A2025And2022RepurchaseProgramMember
2025-03-30
2025-09-27
0000772406
crus:ReportableSegmentMember
2025-06-29
2025-09-27
0000772406
crus:ReportableSegmentMember
2024-06-30
2024-09-28
0000772406
crus:ReportableSegmentMember
2025-03-30
2025-09-27
0000772406
crus:ReportableSegmentMember
2024-03-31
2024-09-28
0000772406
country:IN
2025-06-29
2025-09-27
0000772406
country:IN
2024-06-30
2024-09-28
0000772406
country:IN
2025-03-30
2025-09-27
0000772406
country:IN
2024-03-31
2024-09-28
0000772406
country:HK
2025-06-29
2025-09-27
0000772406
country:HK
2024-06-30
2024-09-28
0000772406
country:HK
2025-03-30
2025-09-27
0000772406
country:HK
2024-03-31
2024-09-28
0000772406
country:VN
2025-06-29
2025-09-27
0000772406
country:VN
2024-06-30
2024-09-28
0000772406
country:VN
2025-03-30
2025-09-27
0000772406
country:VN
2024-03-31
2024-09-28
0000772406
country:KR
2025-06-29
2025-09-27
0000772406
country:KR
2024-06-30
2024-09-28
0000772406
country:KR
2025-03-30
2025-09-27
0000772406
country:KR
2024-03-31
2024-09-28
0000772406
crus:OtherNonUSCountriesMember
2025-06-29
2025-09-27
0000772406
crus:OtherNonUSCountriesMember
2024-06-30
2024-09-28
0000772406
crus:OtherNonUSCountriesMember
2025-03-30
2025-09-27
0000772406
crus:OtherNonUSCountriesMember
2024-03-31
2024-09-28
0000772406
crus:AndrewBrannanMember
2025-06-29
2025-09-27
0000772406
crus:AndrewBrannanMember
2025-09-27
0000772406
crus:JohnForsythMember
2025-06-29
2025-09-27
0000772406
crus:JohnForsythMember
2025-09-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 
10-Q

☑
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended

September 27, 2025
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from ____ to ____
Commission File Number 
0-17795

CIRRUS LOGIC, INC.
(Exact name of registrant as specified in its charter)
Delaware

77-0024818
(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)
800 W. 6th Street
Austin,
Texas
78701
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(512)
851-4000

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, $0.001 par value
CRUS
The NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.  
Yes

☑
   No 
☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding

12 months (or for such shorter period that the registrant was required to submit and post such files).  
Yes

☑
    No  
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
☑
Accelerated Filer
☐
Non-accelerated Filer  
☐
Smaller Reporting Company
☐
Emerging Growth Company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. 
☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  
Yes ☐    No 
☑
The number of shares of the registrant's common stock, $0.001 par value, outstanding as of October 31, 2025 was 
51,030,389
.
CIRRUS LOGIC, INC.
FORM 10-Q QUARTERLY REPORT
QUARTERLY PERIOD ENDED

SEPTEMBER 27, 2025 
TABLE OF CONTENTS
PART I - FINANCIAL INFORMATION

Item 1.
Financial Statements

Consolidated Condensed Balance Sheets - September 27, 2025 (unaudited) and March 29, 2025
3

Consolidated Condensed Statements of Income (unaudited) - Three and Six Months Ended September 27, 2025 and September 28, 2024
4

Consolidated Condensed Statements of Comprehensive Income (unaudited) - Three and Six Months Ended September 27, 2025 and September 28, 2024
5

Consolidated Condensed Statements of Cash Flows (unaudited) - Six Months Ended September 27, 2025 and September 28, 2024
6
Consolidated Condensed Statements of Stockholders' Equity (unaudited) - Three and Six Months Ended September 27, 2025 and September 28, 2024
7
Notes to Consolidated Condensed Financial Statements (unaudited)
8

Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
17

Item 3.
Quantitative and Qualitative Disclosures about Market Risk
21

Item 4.
Controls and Procedures
22

PART II - OTHER INFORMATION

Item 1.
Legal Proceedings
22

Item 1A.
Risk Factors
22

Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
24

Item 3.
Defaults Upon Senior Securities
25

Item 4.
Mine Safety Disclosures
25

Item 5.
Other Information
25

Item 6.
Exhibits
26

Signatures
26
2
Part I.

FINANCIAL INFORMATION
ITEM

1. 

FINANCIAL STATEMENTS
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)
September 27,
March 29,
2025
2025
(unaudited)

Assets

Current assets:

Cash and cash equivalents
$
593,476

$
539,620

Marketable securities
52,424

56,160

Accounts receivable, net
355,397

216,009

Inventories
236,409

299,092

Prepaid assets
51,657

48,236

Prepaid wafers
45,056

52,560

Other current assets
32,581

28,057

Total current assets
1,367,000

1,239,734

Long-term marketable securities
250,146

239,036

Right-of-use lease assets
125,315

126,688

Property and equipment, net
151,154

159,900

Intangibles, net
24,451

27,461

Goodwill
435,936

435,936

Deferred tax assets
46,511

48,150

Long-term prepaid wafers
—

15,512

Other assets
29,170

34,656

Total assets
$
2,429,683

$
2,327,073

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable
$
79,974

$
63,162

Accrued salaries and benefits
52,689

52,075

Software license agreements
26,803

26,745

Current lease liabilities
19,481

21,811

Other accrued liabilities
31,376

31,395

Total current liabilities
210,323

195,188

Long-term liabilities:

Non-current lease liabilities
120,985

121,908

Non-current income taxes
45,357

44,040

Software license agreements
10,576

16,488

Total long-term liabilities
176,918

182,436

Stockholders' equity:

Capital stock
1,903,638

1,860,281

Accumulated earnings
139,025

90,351

Accumulated other comprehensive loss
(
221
)
(
1,183
)
Total stockholders' equity
2,042,442

1,949,449

Total liabilities and stockholders' equity
$
2,429,683

$
2,327,073

The accompanying notes are an integral part of these consolidated condensed financial statements.
3
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(in thousands, except per share amounts; unaudited)
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Net sales
$
560,960

$
541,857

$
968,232

$
915,883

Cost of sales
266,586

259,267

459,828

444,368

Gross profit
294,374

282,590

508,404

471,515

Operating expenses

Research and development
110,021

112,925

212,913

218,288

Selling, general and administrative
39,589

37,813

78,333

74,583

Total operating expenses
149,610

150,738

291,246

292,871

Income from operations
144,764

131,852

217,158

178,644

Interest income
8,938

8,378

17,779

16,798

Interest expense
(
243
)
(
244
)
(
462
)
(
462
)
Other income (expense)
(
63
)
19

(
451
)
1,628

Income before income taxes
153,396

140,005

234,024

196,608

Provision for income taxes
21,800

37,865

41,731

52,373

Net income
$
131,596

$
102,140

$
192,293

$
144,235

Basic earnings per share
$
2.57

$
1.92

$
3.74

$
2.70

Diluted earnings per share
$
2.48

$
1.83

$
3.61

$
2.59

Basic weighted average common shares outstanding
51,175

53,275

51,451

53,354

Diluted weighted average common shares outstanding
53,054

55,800

53,195

55,753

The accompanying notes are an integral part of these consolidated condensed financial statements.
4
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands; unaudited)
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Net income
$
131,596

$
102,140

$
192,293

$
144,235

Other comprehensive loss, before tax

Foreign currency translation gain (loss)
(
209
)
717

560

359

Unrealized gain on marketable securities
267

4,851

509

4,493

Provision for income taxes
(
56
)
(
1,019
)
(
107
)
(
944
)
Comprehensive income 
$
131,598

$
106,689

$
193,255

$
148,143

The accompanying notes are an integral part of these consolidated condensed financial statements.
5
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(in thousands; unaudited)
Six Months Ended
September 27,
September 28,
2025
2024
Cash flows from operating activities:

Net income
$
192,293

$
144,235

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization
25,877

24,977

Stock-based compensation expense
41,406

43,832

Deferred income taxes
1,532

(
913
)
Loss on retirement or write-off of long-lived assets
—

12

Other non-cash adjustments
52

1,191

Net change in operating assets and liabilities:

Accounts receivable
(
139,388
)
(
161,620
)
Inventories
62,683

(
44,517
)
Prepaid wafers
23,016

37,885

Other assets
(
6,471
)
(
5,800
)
Accounts payable and other accrued liabilities
20,645

39,305

Income taxes payable
(
13,300
)
16,805

Net cash provided by operating activities
208,345

95,392

Cash flows from investing activities:

Maturities and sales of available-for-sale marketable securities
62,742

13,481

Purchases of available-for-sale marketable securities
(
69,606
)
(
72,637
)
Purchases of property, equipment and software
(
6,506
)
(
12,660
)
Investments in technology
(
774
)
(
225
)
Net cash used in investing activities
(
14,144
)
(
72,041
)

Cash flows from financing activities:

Net proceeds from the issuance of common stock
1,950

15,055

Repurchase of stock to satisfy employee tax withholding obligations
(
2,310
)
(
4,426
)
Repurchase and retirement of common stock
(
139,985
)
(
90,985
)
Net cash used in financing activities
(
140,345
)
(
80,356
)

Net increase (decrease) in cash and cash equivalents
53,856

(
57,005
)

Cash and cash equivalents at beginning of period
539,620

502,764

Cash and cash equivalents at end of period
$
593,476

$
445,759

The accompanying notes are an integral part of these consolidated condensed financial statements.
6
CIRRUS LOGIC, INC.
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands; unaudited)
Common Stock
Additional Paid-In Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Total
Three Months Ended
Shares
Amount
Balance, June 29, 2024
53,335

$
53

$
1,792,230

$
58,591

$
(
3,244
)
$
1,847,630

Net income
— 
— 
— 
102,140

— 
102,140

Change in unrealized gain (loss) on marketable securities, net of tax
— 
— 
— 
— 
3,832

3,832

Change in foreign currency translation adjustments
— 
— 
— 
— 
717

717

Issuance of stock under stock option plans and other, net of shares withheld for employee taxes
154

— 
4,859

(
3,207
)
— 
1,652

Repurchase and retirement of common stock
(
357
)
— 
— 
(
50,291
)
— 
(
50,291
)
Stock-based compensation
— 
— 
22,447

— 
— 
22,447

Balance, September 28, 2024
53,132

$
53

$
1,819,536

$
107,233

$
1,305

$
1,928,127

Balance, June 28, 2025
51,314

$
51

$
1,881,421

$
49,035

$
(
223
)
$
1,930,284

Net income
— 
— 
— 
131,596

— 
131,596

Change in unrealized gain (loss) on marketable securities, net of tax
— 
— 
— 
— 
211

211

Change in foreign currency translation adjustments
— 
— 
— 
— 
(
209
)
(
209
)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes
66

— 
1,569

(
1,262
)
— 
307

Repurchase and retirement of common stock
(
362
)
— 
— 
(
40,344
)
— 
(
40,344
)
Stock-based compensation
— 
— 
20,597

— 
— 
20,597

Balance, September 27, 2025
51,018

$
51

$
1,903,587

$
139,025

$
(
221
)
$
2,042,442

Six Months Ended
Balance, March 30, 2024
53,491

$
53

$
1,760,648

$
58,916

$
(
2,603
)
$
1,817,014

Net income
— 
— 
— 
144,235

— 
144,235

Change in unrealized gain (loss) on marketable securities, net of tax
— 
— 
— 
— 
3,549

3,549

Change in foreign currency translation adjustments
— 
— 
— 
— 
359

359

Issuance of stock under stock option plans and other, net of shares withheld for employee taxes
359

— 
15,056

(
4,426
)
— 
10,630

Repurchase and retirement of common stock
(
718
)
— 
— 
(
91,492
)
— 
(
91,492
)
Stock-based compensation
— 
— 
43,832

— 
— 
43,832

Balance, September 28, 2024
53,132

$
53

$
1,819,536

$
107,233

$
1,305

$
1,928,127

Balance, March 29, 2025
52,291

$
52

$
1,860,229

$
90,351

$
(
1,183
)
$
1,949,449

Net income
— 
— 
— 
192,293

— 
192,293

Change in unrealized gain (loss) on marketable securities, net of tax
— 
— 
— 
— 
402

402

Change in foreign currency translation adjustments
— 
— 
— 
— 
560

560

Issuance of stock under stock option plans and other, net of shares withheld for employee taxes
103

— 
1,952

(
2,311
)
— 
(
359
)
Repurchase and retirement of common stock
(
1,376
)
(
1
)
— 
(
141,308
)
— 
(
141,309
)
Stock-based compensation
— 
— 
41,406

— 
— 
41,406

Balance, September 27, 2025
51,018

$
51

$
1,903,587

$
139,025

$
(
221
)
$
2,042,442

The accompanying notes are an integral part of these consolidated condensed financial statements.
7
CIRRUS LOGIC, INC.
NOTES TO THE CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(unaudited)
1.  
Basis of Presentation
The unaudited consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”).  The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations.  As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 29, 2025, included in our Annual Report on Form 10-K filed with the Commission on May 23, 2025.  In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented.  The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses.  Actual results could differ from those estimates and assumptions.  Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.

2.  
Recently Issued Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, 
Income Taxes (Topic 740) - Improvements to Income Tax Disclosures
.  The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction.  This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted.  The Company is currently evaluating the impact of this guidance on financial statement disclosures and expects to provide these disclosures in the fourth quarter of fiscal year 2026.
In November 2024, the FASB issued ASU 2024-03, 
Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220-40): Disaggregation of Income Statement Expenses
, which requires disaggregation of certain expense categories in the notes to the financial statements in order to provide enhanced transparency into the expense captions presented on the face of the income statement.  The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption and prospective or retrospective application permitted.  The Company is currently evaluating the impact of this guidance on financial statement disclosures.
In September 2025, the FASB issued ASU 2025-06, 
Intangibles – Goodwill and Other – Internal-Use Software (Topic 350-40): Targeted Improvements to the Accounting for Internal-Use Software
, which removes references to software development stages, or “project stages,” in assessing the timing of software cost capitalization.  The amendments are effective for annual reporting periods beginning after December 15, 2027, and interim periods within those annual reporting periods.  Early adoption is permitted using the prospective, modified, or retrospective transition methods.  The Company is currently evaluating the impact of this guidance on financial statement disclosures.
3.  
Marketable Securities
The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the Consolidated Condensed Balance Sheet as “
Marketable securities
,” within the short-term or long-term classification, as appropriate, based on the original maturity.

The following table is a summary of available-for-sale securities at September 27, 2025 (in thousands):
As of September 27, 2025
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities
$
298,125

$
2,143

$
(
35
)
$
300,233

U.S. Treasury securities
2,314

23

—

2,337

Total securities
$
300,439

$
2,166

$
(
35
)
$
302,570

The Company typically invests in highly-rated securities with original maturities generally ranging from 
one
 to 
three years
.  The Company's specifically identified gross unrealized losses were immaterial related to securities with total amortized 
8
costs of approximately $
18.2
 million at

September 27, 2025.  There were no securities in a continuous unrealized loss position for more than 12 months as of September 27, 2025.  The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management.  The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors.  When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis.  As of September 27, 2025, the Company does not consider any of its investments to be impaired.
The following table is a summary of available-for-sale securities at March 29, 2025 (in thousands):
As of March 29, 2025
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated
Fair Value
(Net Carrying
Amount)
Corporate debt securities
$
284,885

1,635

$
(
55
)
$
286,465

U.S. Treasury securities
8,689

45

(
3
)
8,731

Total securities
$
293,574

$
1,680

$
(
58
)
$
295,196

The Company's specifically identified gross unrealized losses of $
0.1
 million related to securities with total amortized costs of approximately $
29.8
 million at

March 29, 2025.  Securities in a continuous unrealized loss position for more than 12 months as of March 29, 2025 had an aggregate amortized cost of $
1.9
 million and an immaterial aggregate unrealized loss. 

As of

March 29, 2025, the Company did not consider any of its investments to be impaired.
The cost and estimated fair value of available-for-sale

securities

by contractual maturities were as follows

(in thousands):
September 27, 2025
March 29, 2025
Amortized
Estimated
Amortized
Estimated
Cost
Fair Value
Cost
Fair Value
Within 1 year
$
52,111

$
52,424

$
56,044

$
56,160

After 1 year
248,328

250,146

237,530

239,036

Total
$
300,439

$
302,570

$
293,574

$
295,196

4.

Fair Value of Financial Instruments
The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio.  The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
•
Level 1 - Quoted prices in active markets for identical assets or liabilities.
•
Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
•
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, and U.S Treasury securities, and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term marketable securities.  The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.
9
The Company's long-term revolving credit facility, described in Note 8 - Revolving Credit Facility, bears interest at a base rate plus applicable margin or forward-looking secured overnight financing rate (“Term SOFR”) plus 
10
 basis points plus applicable margin.  As of September 27, 2025, there are 
no
 amounts drawn under the facility and the fair value is 
zero
.
As of September 27, 2025 and March 29, 2025, the Company has no Level 3 assets or liabilities.  There were no transfers between Level 1, Level 2, or Level 3 measurements for the three months ended September 27, 2025. 
The following summarizes the fair value of our financial instruments at September 27, 2025 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:

Cash equivalents

Money market funds
$
543,774

$
—

$
—

$
543,774

Available-for-sale securities

Corporate debt securities
$
—

$
300,233

$
—

$
300,233

U.S. Treasury securities
2,337

—

—

2,337

$
2,337

$
300,233

$
—

$
302,570

The following summarizes the fair value of our financial instruments at March 29, 2025 (in thousands):
Quoted Prices
in Active
Markets for
Identical
Assets
Level 1
Significant
Other
Observable
Inputs
Level 2
Significant
Unobservable
Inputs
Level 3
Total
Assets:
Cash equivalents

Money market funds
491,467

—

—

491,467

Available-for-sale securities

Corporate debt securities
$
—

$
286,465

$
—

$
286,465

U.S. Treasury securities
8,731

—

—

8,731

$
8,731

$
286,465

$
—

$
295,196

5.

Derivative Financial Instruments
Foreign Currency Forward Contracts
The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures.  The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within “
Other income (expense)
” in the Consolidated Condensed Statements of Income.  The Company does not apply hedge accounting to these foreign currency derivative instruments.
As of September 27, 2025, the Company held 
one
 foreign currency forward contract denominated in British Pound Sterling with a notional value of $
19.2
 million.  The fair value of this contract was not material as of September 27, 2025.
10
The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands):
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Location
Gain (loss) recognized in income:
Foreign currency forward contracts
$
(
266
)
$
684

$
898

$
652

Other income (expense)
6.

Accounts Receivable, net
The following are the components of accounts receivable, net (in thousands):
September 27,
March 29,
2025
2025
Gross accounts receivable
$
355,397

$
216,009

Allowance for doubtful accounts
—

—

Accounts receivable, net
$
355,397

$
216,009

The increase in accounts receivable is due to the timing of collections and billings during the quarter.
7. 
Inventories
Inventories are comprised of the following (in thousands):
September 27,
March 29,
2025
2025
Work in process
$
182,307

$
216,173

Finished goods
54,102

82,919

$
236,409

$
299,092

8. 
Revolving Credit Facility
On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto.  The Second Amended Credit Agreement provides for a $
300
 million senior secured revolving credit facility (the “Revolving Credit Facility”).  The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”).  The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the “Subsidiary Guarantors”).  The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.
On March 20, 2023, the Company, entered into the First Amendment (the “Amendment”) to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent.  The Amendment updates the benchmark interest rate provisions to replace the London interbank offered rate (“LIBOR”) with Term SOFR, for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.
Borrowings under the Revolving Credit Facility may bear interest, at Cirrus Logic’s election, at either (a) a base rate plus the applicable margin (“Base Rate Loans”) or (b) a Term SOFR rate plus a 
10
 basis point credit spread adjustment plus the applicable margin.  The applicable margin ranges from 
0
% to 
0.75
% per annum for Base Rate Loans and 
1.00
% to 
1.75
% per annum for SOFR Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of four consecutive fiscal quarters (the “Consolidated Leverage Ratio”).  A Commitment Fee accrues at a rate per annum ranging from 
0.175
% to 
0.275
% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders.
11
The Revolving Credit Facility contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $
200
 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 
3.00
 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 
3.00
 to 1.00 (the “Consolidated Interest Coverage Ratio”).  The Second Amended Credit Agreement also contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments.  Further, the Second Amended Credit Agreement  contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations.
As of September 27, 2025, the Company had 
no
 amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.
9.

Revenues
Disaggregation of revenue
We disaggregate revenue from contracts with customers by product line and ship to location of the customer.  Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal (“HPMS”).
Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands).   
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Audio Products
$
318,214

$
316,588

$
558,257

$
535,558

HPMS Products
242,746

225,269

409,975

380,325

$
560,960

$
541,857

$
968,232

$
915,883

The geographic regions that are reviewed are China, the United States, and the rest of the world.  Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
China
$
302,950

$
325,742

$
492,905

$
531,450

United States
3,033

2,471

7,681

7,687

Rest of World
254,977

213,644

467,646

376,746

$
560,960

$
541,857

$
968,232

$
915,883

10.

Income Taxes
Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, and any applicable income tax credits.
12
The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Income before income taxes
$
153,396

$
140,005

$
234,024

$
196,608

Provision for income taxes
$
21,800

$
37,865

$
41,731

$
52,373

Effective tax rate
14.2

%
27.0

%
17.8

%
26.6

%
Our income tax expense was $
21.8
 million and $
37.9
 million for the second quarters of fiscal years 2026 and 2025, respectively, resulting in effective tax rates of 
14.2
 percent and 
27.0
 percent, respectively.  Our income tax expense was $
41.7
 million and $
52.4
 million for the first six months of fiscal years 2026 and 2025, respectively, resulting in effective tax rates of 
17.8
 percent and 
26.6
 percent, respectively. 
Effective tax rates for fiscal year 2025 were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that required research and development (“R&D”) expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, which resulted in increased GILTI inclusions in these periods.  In addition, those periods were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI.  
The effective tax rates for the second quarter and first six months of fiscal year 2026 were lower than the prior periods presented due to the current quarter enactment of the legislation commonly referred to as the One Big Beautiful Bill Act (“OBBBA”), which was signed into law on July 4, 2025. The OBBBA includes a broad range of tax reform provisions and extends or modifies several provisions initially enacted by the Tax Cuts and Jobs Act of 2017. Beginning with fiscal year 2026, the OBBBA permanently eliminates the requirement to capitalize and amortize U.S. R&D expenditures. A number of other provisions of the OBBBA, including modifications to existing international tax provisions, will take effect in fiscal year 2027. 
In connection with its initial analysis of the OBBBA, the Company determined that its forecasted annual effective tax rate for fiscal year 2026 decreased, primarily due to U.S. R&D expenditures no longer being capitalized within GILTI (renamed by the OBBBA as net controlled foreign corporation tested income), which the Company has elected to treat as a period cost.  
The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns.  At September 27, 2025, the Company had unrecognized tax benefits of $
32.1
 million, all of which would impact the effective tax rate if recognized.  The Company’s total unrecognized tax benefits are classified as “
Non-current income taxes
” in the Consolidated Condensed Balance Sheets.  The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes.  As of September 27, 2025, the balance of accrued interest and penalties, net of tax, was $
13.3
 million.  
On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid.  In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”).  On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations.  On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020.  Although the issue is now resolved in the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits.  The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time.  We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years.
The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions.  Fiscal years 2017 through 2019 and 2022 through 2025 remain open to examination by the major taxing jurisdictions in which the Company operates.   
The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service (“IRS”).  The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies.  The final Revenue Agent’s Report asserted additional tax of approximately $
168.3
 million, excluding interest, and imposed penalties of approximately $
63.7
 million.  The Company does not agree with the IRS's positions and has not accrued an additional liability.  In July 2024, the Company entered the administrative dispute process with the IRS Independent Office of Appeals (“IRS Appeals”).  We intend to vigorously dispute 
13
the proposed adjustments and pursue judicial remedies if an acceptable outcome cannot be reached with IRS Appeals.  The Company expects it could take a number of years to reach resolution on these matters.  Although the final resolution of these matters is uncertain, the Company believes adequate amounts have been reserved in accordance with ASC 740 for any adjustments to the provision for income taxes that may ultimately result.  However, if the IRS prevails in these matters, the ultimate amount of assessed tax, interest, and penalties, if any, could be material and may have an adverse impact on our financial position, results of operations, and cash flows in future periods.  The Company is not under an income tax audit in any other major taxing jurisdiction.
11.

Net Income Per Share
Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  These potentially dilutive items consist primarily of outstanding stock options and restricted stock units.
The following table details the calculation of basic and diluted earnings per share for the three and six months ended September 27, 2025 and September 28, 2024 (in thousands, except per share amounts):
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Numerator:

Net income
$
131,596

$
102,140

$
192,293

$
144,235

Denominator:

Weighted average shares outstanding
51,175

53,275

51,451

53,354

Effect of dilutive securities
1,879

2,525

1,744

2,399

Weighted average diluted shares
53,054

55,800

53,195

55,753

Basic earnings per share
$
2.57

$
1.92

$
3.74

$
2.70

Diluted earnings per share
$
2.48

$
1.83

$
3.61

$
2.59

The weighted outstanding shares excluded from our diluted calculation for the three and six months ended September 27, 2025 were 
65
 thousand and 
252
 thousand, respectively, as the shares were anti-dilutive.  The weighted outstanding shares excluded from our diluted calculation for the three and six months ended September 28, 2024 were 
8
 thousand and 
229
 thousand, respectively, as the shares were anti-dilutive.

12. 
Commitments and Contingencies
Capacity Reservation Agreement
On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GlobalFoundries to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”).  On February 18, 2025, the Capacity Reservation Agreement was amended (the “Amendment”) to define the quarterly spread of the remaining wafer quantities under the agreement.
The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments.  In exchange for GlobalFoundries’ capacity commitment, the Company paid a $
60
 million non-refundable capacity reservation fee, which is amortized over the Commitment Period.  The balance of this reservation fee is $
12
 million as of September 27, 2025, and is recorded in “
Other current assets
” and “
Other assets
” on the Consolidated Condensed Balance Sheets within the short-term or long-term classification, as appropriate.  In addition, the Company pre-paid GlobalFoundries $
195
 million for future wafer purchases, which are credited back to the Company as a portion of the price of wafers purchased, which began in the Company's second fiscal quarter of 2024.  The balance of the prepayment is $
45
 million at September 27, 2025, and is currently recorded in “
Prepaid wafers
” on the Consolidated Condensed Balance Sheets.
14
Lease Agreement
In the second quarter of fiscal year 2026, the Company commenced a 
10
-year operating lease for corporate office space in Greensboro, North Carolina. As a result, the Company recognized a liability of $
4.8
 million for future lease payments and a corresponding right-of-use lease asset.  Lease liabilities and right-of-use lease assets are presented separately on the Consolidated Condensed Balance Sheets as of September 27, 2025.
13.

Legal Matters
From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities.  We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate.  We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.    
Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows.  However, we are engaged in various legal actions in the normal course of business.  There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.
14.

Stockholders' Equity
Common Stock
The Company issued a net 
0.1
 million shares of common stock during the three and six months ended September 27, 2025, respectively, and issued a net 
0.2
 million and 
0.4
 million
 shares of common stock for the three and six months ended September 28, 2024, respectively, pursuant to the Company's equity incentive plans.
Share Repurchase Program

The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, which is included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity.  As of September 27, 2025, approximately 
$
1.3
 million
 is accrued related to this excise tax.  Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.
In July 2022, the Board of Directors authorized the repurchase of up to $
500
 million of the Company's stock.  During the three months ended June 28, 2025, the Company completed share repurchases under the 2022 authorization.  In March 2025
, the Board of Directors authorized the repurchase of up to an additional 
$
500
 million
 of the Company's common stock
.  
As of September 27, 2025, a
pproximately
 $
85.9
 million of the Company's common stock has been repurchased, leaving approximately $
414.1
 million available for repurchase under the 2025 authorization
.  Du
ring the three months ended September 27, 2025, the Company repurchased 
0.4
 million shares of the Company's common stock for $
40.0
 million, at an average cost of $
110.55
 per share under the 2025 authorization.  During the six months ended September 27, 2025, the Company repurchased 
1.4
 million of the Company's common stock for $
140.0
 million, at an average cost of $
101.78
 per share under the combined share authorizations.

15.

Segment Information
We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker (“CODM”) under these guidelines. 
The Company operates and tracks its results in 
one
 reportable segment, but reports revenue in 
two
 product lines, Audio and HPMS.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources.  Our product lines have similar characteristics and customers and share operations support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology. Therefore, there is no 
15
complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.
The CODM evaluates Company performance based on net income, and this information is used to measure profitability, make budgeting and forecasting decisions, monitor performance trends, and to compare actual results to forecasts. The CODM regularly reviews the consolidated statement of income and a disaggregation of operating expenses, with a focus on personnel-related and product development expenses. The measure of segment assets is reported on the balance sheet as total consolidated assets.
The table below presents the Company's significant segment operating expenses (in thousands):
Three Months Ended
Six Months Ended
September 27, 2025
September 28, 2024
September 27, 2025
September 28, 2024
Personnel-related (1)
$
91,148

$
89,280

$
179,467

$
173,778

Product development (2)
16,550

17,497

30,281

32,413

Other segment items (3)
41,912

43,961

81,498

86,680

Total Operating Expense
$
149,610

$
150,738

$
291,246

$
292,871

(1) Personnel-related expenses include variable compensation and employee-related expenses, which primarily include employee base pay and benefit expenses.
(2) Product development costs include software, engineering mask sets, wafers, and boards, as well as outside design services.
(3) Other segment items primarily include stock-based compensation, facilities-related costs, depreciation and amortization, and non-recurring charges, offset by the benefit received from research and development expenditure credits.
Geographic Area
The Company's geographic details of revenue are included below.
The following illustrates net sales by ship to location of the customer (in thousands):
Three Months Ended
Six Months Ended
September 27, 2025
September 28, 2024
September 27, 2025
September 28, 2024
China
$
302,950

$
325,742

$
492,905

$
531,450

India
69,765

41,650

145,194

79,682

Hong Kong
69,335

62,356

118,510

104,005

Vietnam
57,464

42,251

93,727

68,534

South Korea
34,238

46,709

67,131

85,592

United States
3,033

2,471

7,681

7,687

Rest of World
24,175

20,678

43,084

38,933

Total consolidated sales
$
560,960

$
541,857

$
968,232

$
915,883

16
ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read along with the unaudited consolidated condensed financial statements and notes thereto included in Item 1 of this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the fiscal year ended March 29, 2025, contained in our fiscal year 2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on May 23, 2025. 

We maintain a website at 
investor.cirrus.com
, which makes available free of charge our

most

recent annual report and

all

other filings

we have made

with the

Commission. 
Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q including Management’s Discussion and Analysis of Financial Condition and Results of Operations and certain information incorporated herein by reference contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  These forward-looking statements are based on expectations, estimates, forecasts and projections and the beliefs and assumptions of our management as of the filing of this Form 10-Q.  In some cases, forward-looking statements are identified by words such as “expect,” “anticipate,” “target,” “project,” “believe,” “goals,” “estimates,” “intend,” and variations of these types of words and similar expressions which are intended to identify these forward-looking statements.  In addition, any statements that refer to our plans, expectations, strategies or other characterizations of future events or circumstances are forward-looking statements.  Readers are cautioned that these forward-looking statements are predictions and are subject to risks, uncertainties and assumptions that are difficult to predict.  Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements and readers should not place undue reliance on such statements.  We undertake no obligation, and expressly disclaim any duty, to revise or update publicly any forward-looking statement for any reason, except as required by law.
For additional information regarding known material factors that could cause our actual results to differ from our projected results, please see

“Item 1A - Risk Factors”

in our 2025 Annual Report

on Form 10-K filed with the Commission on

May 23, 2025,

and in “
Part II, Item 1A
 - 
Risk Factors
” within this Quarterly Report on Form 10-Q.  Readers should carefully review these risk factors, as well as those identified in other documents filed by us with the Commission. 
Overview
Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) is a leader in low-power, high-precision mixed-signal processing solutions that create innovative user experiences for the world’s top mobile and consumer applications.
The Company remains committed to our three-pronged strategy for growing our business: first, maintaining our leadership position in smartphone audio; second, increasing HPMS content in smartphones; and third, leveraging our strength in audio and HPMS to expand into additional applications and markets with new and existing components.  During the second quarter of fiscal year 2026, we continued to execute on these strategic initiatives.  We were delighted to see multiple smartphone customers introduce their latest generation devices featuring our audio and HPMS components.  Outside of smartphones, we continued to execute on our plan to grow market share in the PC market.  Progress in this space included securing our first mainstream consumer laptop design, expanding our collaboration with leading System-on-a-Chip (SoC) vendors, and developing new products with superior voice and audio capture capabilities.  Additionally, we continue to focus on our general market business.  During the quarter, we gained design momentum with customers on our latest-generation ADCs, DACs, and ultra-high-performance audio codec.  We also received positive initial feedback on our family of analog front-end components targeting imaging applications and saw increased engagement on our latest timing product family.  Looking forward, we are optimistic about the opportunities ahead of us as we continue to seek to leverage our mixed-signal design and signal processing expertise to diversify our product portfolio and expand our addressable market.    
Critical Accounting Policies and Estimates
Our discussion and analysis of the Company’s financial condition and results of operations are based upon the unaudited consolidated condensed financial statements included in this report, which have been prepared in accordance with U.S. GAAP.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts.  We evaluate the estimates on an ongoing basis.  We base these estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making 
17
judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions and conditions. 
There have been no significant changes during the three and six months ended September 27, 2025, to the information provided under the headings “
Critical Accounting Estimates
” and “
Summary of Significant Accounting Policies
” included in our fiscal year 2025 Annual Report on Form 10-K for the fiscal year ended March 29, 2025.
Recently Issued Accounting Pronouncements
For a discussion of recently issued accounting pronouncements, refer to Note 2 of the Notes to the Consolidated Condensed Financial Statements. 
Results of Operations

Our fiscal year is the 52- or 53-week period ending on the last Saturday in March.  Fiscal years 2026 and 2025 are 52-week fiscal years.    
The following table summarizes the results of our operations for the 
three and six
 months of fiscal years 2026

and

2025, respectively,

as a

percentage

of net sales.  All

percentage

amounts were calculated using the underlying data in thousands, unaudited:
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Net sales
100 
%
100 
%
100 
%
100 
%
Gross margin
53 
%
52 
%
53 
%
52 
%
Research and development
20 
%
21 
%
22 
%
24 
%
Selling, general and administrative
7 
%
7 
%
9 
%
8 
%
Income from operations
26 
%
24 
%
22 
%
20 
%
Interest income
1 
%
2 
%
2 
%
2 
%
Interest expense
— 
%
— 
%
— 
%
— 
%
Other income (expense)
— 
%
— 
%
— 
%
— 
%
Income before income taxes
27 
%
26 
%
24 
%
22 
%
Provision for income taxes
4 
%
7 
%
4 
%
6 
%
Net income
23 
%
19 
%
20 
%
16 
%
Net Sales 
Net sales for the second quarter of fiscal year 2026 increased $19.1 million, or 4 percent, to $561.0 million from $541.9 million in the second quarter of fiscal year 2025.  Net sales from our audio products increased $1.6 million, primarily driven by higher smartphone unit volumes in the second quarter of fiscal year 2026 and sales associated with latest-generation products, partially offset by declines in average sales prices (“ASPs”).  Net sales from HPMS products increased $17.5 million for the quarter versus the second quarter of fiscal year 2025, primarily due to higher general market sales, smartphone unit volumes and sales associated with latest-generation products, partially offset by declines in ASPs.  

Net sales for the first six months of fiscal year 2026 increased $52.3 million, or 6 percent, to $968.2 million from $915.9 million for the first six months of fiscal year 2025.  Net sales from our audio products increased $22.7 million, primarily driven by higher smartphone unit volumes and sales associated with latest-generation products, partially offset by declines in ASPs.  Net sales from HPMS products increased $29.7 million for the year versus the first six months of fiscal year 2025, primarily due to higher general market sales, smartphone unit volumes, and sales associated with latest-generation products, partially offset by declines in ASPs.
International sales, including sales to U.S.-based end customers that manufacture products through contract manufacturers or plants located overseas, were approximately 99 percent and 100 percent of net sales for the second quarters of 
18
fiscal years 2026 and 2025, respectively, and 99 percent for each of the first six month periods of fiscal years 2026 and 2025.  Our sales are denominated primarily in U.S. dollars. 
Since the components we produce are largely proprietary, we consider our end customer to be the entity specifying the use of our component in their design.  These end customers may purchase our products directly from us, through distributors, or third-party manufacturers contracted to produce their

designs.  For each of the

second

quarters of fiscal years 2026

and 2025, our ten largest end customers represented approximately

97 percent, of our net sales, and 97 percent and 96 percent of our net sales for the first six months of fiscal years 2026 and 2025, respectively.      
We had one end customer, Apple Inc., that purchased through multiple contract manufacturers and represented approximately 90 percent of the Company’s total net sales for each of the second quarters of fiscal years 2026 and 2025, and 88 percent and 89 percent for the first six months of fiscal years 2026 and 2025, respectively.  

No other end customer or distributor represented more than 10 percent of net sales for the three and six months ended September 27, 2025

or

September 28, 2024.  
For more information, please see “
Part II, Item 1A - Risk Factors
”

—

“We depend on a limited number of customers and distributors for a substantial portion of our sales, and the loss of, or a significant reduction in orders from,

or pricing on products sold to,

any key customer or distributor could significantly reduce our sales

and our profitability.”
Gross Margin
Gross margin was 52.5 percent in the second quarter of fiscal year 2026, up from 52.2 percent in the second quarter of fiscal year 2025, largely due to a more favorable product mix, partially offset by higher inventory reserves.
Gross margin was 52.5 percent for the first six months of fiscal year 2026, up from 51.5 percent for the first six months of fiscal year 2025 due to a more favorable product mix, partially offset by higher inventory reserves.
Research and Development Expense
Research and development expense for the second quarter of fiscal year 2026 was $110.0 million, a decrease of $2.9 million, from $112.9 million in the second quarter of fiscal year 2025.  Significant drivers included reduced stock-based compensation and product development costs, partially offset by increased employee-related costs in the current quarter.
Research and development expense for the first six months of fiscal year 2026 was $212.9 million, a decrease of $5.4 million, from $218.3 million for the first six months of fiscal year 2025, primarily due to reduced stock-based compensation, product development, and facilities-related costs, partially offset by increased employee-related costs for the period.
Selling, General and Administrative Expense
Selling, general and administrative expense for the second quarter of fiscal year 2026 was $39.6 million, an increase of $1.8 million, from $37.8 million in the second quarter of fiscal year 2025, due primarily to increased stock-based compensation costs.
Selling, general and administrative expense for the first six months of fiscal year 2026 was $78.3 million, an increase of $3.8 million, from $74.6 million for the first six months of fiscal year 2025, primarily due to increased stock-based compensation and employee-related expenses, partially offset by the non-recurring lease impairment costs related to the prior comparable period.
Interest Income
The Company reported interest income of $8.9 million and $17.8 million for the three and six months ended September 27, 2025, respectively, and $8.4 million and $16.8 million for the three and six months ended September 28, 2024, respectively.  Interest income increased in the current period due to

returns generated from higher combined average cash, cash equivalents and marketable securities balances, compared to the

prior

period.
19
Interest Expense
The Company reported interest expense of $0.2 million and $0.5 million for the three and six months ended September 27, 2025, respectively, and $0.2 million and $0.5 million for the three and six months ended September 28, 2024, respectively.  Interest expense consists primarily of commitment fees associated with the Company's Revolving Credit Facility (see Note 8 - Revolving Credit Facility of the Notes to the Consolidated Condensed Financial Statements).
Other Income (Expense)
For the three and six months ended September 27, 2025, the Company reported other expense of $0.1 million and $0.5 million, respectively.  For the three and six months ended September 28, 2024, the Company reported other income of an immaterial amount and $1.6 million, respectively.  This activity primarily

related to non-investment related income (expense) and remeasurement on

foreign currency

denominated monetary assets and liabilities.

Income Taxes
Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items and any applicable credits. 
The following table presents the provision for income taxes (in thousands) and the effective tax rates:
Three Months Ended
Six Months Ended
September 27,
September 28,
September 27,
September 28,
2025
2024
2025
2024
Income before income taxes
$
153,396 
$
140,005 
$
234,024 
$
196,608 
Provision for income taxes
$
21,800 
$
37,865 
$
41,731 
$
52,373 
Effective tax rate
14.2 
%
27.0 
%
17.8 
%
26.6 
%
Our income tax expense for the second quarter of fiscal year 2026 was $21.8 million compared to $37.9 million for the second quarter of fiscal year 2025, resulting in effective tax rates of 14.2 percent and 27.0 percent, respectively.  Our income tax expense was $41.7 million and $52.4 million for the first six months of fiscal years 2026 and 2025, respectively, resulting in effective tax rates of 17.8 percent and 26.6 percent, respectively. 
Effective tax rates for fiscal year 2025 were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that required research and development (“R&D”) expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, which resulted in increased GILTI inclusions in these periods.  In addition, those periods were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI.  
The effective tax rates for the second quarter and first six months of fiscal year 2026 were lower than the prior periods presented due to the current quarter enactment of the legislation commonly referred to as the One Big Beautiful Bill Act (“OBBBA”), which was signed into law on July 4, 2025.  The OBBBA includes a broad range of tax reform provisions and extends or modifies several provisions initially enacted by the Tax Cuts and Jobs Act of 2017.  Beginning with fiscal year 2026, the OBBBA permanently eliminates the requirement to capitalize and amortize U.S. R&D expenditures.  A number of other provisions of the OBBBA, including modifications to existing international tax provisions, will take effect in fiscal year 2027. 
In connection with its initial analysis of the OBBBA, the Company determined that its forecasted annual effective tax rate for fiscal year 2026 decreased, primarily due to U.S. R&D expenditures no longer being capitalized within GILTI (renamed by the OBBBA as net controlled foreign corporation tested income), which the Company has elected to treat as a period cost. 
Liquidity and Capital Resources 
We require cash to fund our operating expenses and working capital requirements, including outlays for inventory, capital expenditures, share repurchases, and strategic acquisitions.  Our principal sources of liquidity are cash on hand, cash generated from operations, cash generated from the sale and maturity of marketable securities, and available borrowings under our $300 million Revolving Credit Facility. 
20
Cash generated from our operating activities is net income adjusted for certain non-cash items and changes in working capital.  Cash generated from operations was

$208.3 million for the first

six months

of fiscal year 2026

versus $95.4 million generated for the

corresponding period of fiscal year 2025.  The cash

flow from

operations during the

first six months of fiscal year 2026 was related to the cash components of our net income and a $52.8 million unfavorable change in working capital, primarily as a result of an increase in accounts receivables and decreases in income taxes payables, partially offset by decreases in inventory, and increases in prepaid wafer usage (related to the Capacity Reservation Agreement) and accounts payable and other accrued liabilities.  The cash flow from operations during the corresponding period of fiscal year 2025 was related to the cash components of our net income and a $117.9 million unfavorable change in working capital, primarily as a result of increases in accounts receivables and inventory, partially offset by increases in accounts payable and other accrued liabilities, prepaid wafer usage (related to the Capacity Reservation Agreement), and income taxes payable.       
Net cash

used in investing activities was $14.1 million during the first six months of fiscal year 2026 versus $72.0 million during the first six months of fiscal year 2025.  The cash used in investing activities in the first six months of fiscal year 2026 was related to net purchases of marketable securities of $6.9 million and capital expenditures and technology investments of $7.3 million.  The cash used in investing activities in the corresponding period in fiscal year 2025 was related to net purchases of marketable securities of $59.2 million and capital expenditures and technology investments of $12.9 million. 
Net cash used in financing activities was $140.3 million during the first six months of fiscal year 2026 and was primarily associated with stock repurchases for the period of $140.0 million.  The cash used in financing activities during the first six months of fiscal year 2025 of $80.4 million was primarily associated with stock repurchases during the period of $91.0 million, partially offset by $10.6 million in net proceeds from the issuance of common stock, primarily related to stock option exercises.
Our future capital requirements will depend on many factors, including the rate of sales growth, market acceptance of our products, the timing and extent of research and development projects, potential future acquisitions of companies or technologies, inventory build, and commitments under the Capacity Reservation Agreement with GlobalFoundries (discussed further in Note 12 - Commitments and Contingencies of the Notes to the Consolidated Condensed Financial Statements).  We believe our expected future cash earnings, existing cash, cash equivalents, investment balances, and available borrowings under our Revolving Credit Facility will be sufficient to meet our capital requirements both domestically and internationally, in the short-term (i.e. the next 12 months) and in the long-term, although we could be required, or could elect, to seek additional funding prior to that time. 
Revolving Credit Facility
On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto.  The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”).  The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”).  The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (“Subsidiary Guarantors”).  The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.
On March 20, 2023, the Company, entered into the First Amendment (the “Amendment”) to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent.  The Amendment updates the benchmark interest rate provisions to replace LIBOR with Term SOFR, for the purposes of calculating interest under the terms of the Second Amended Credit Agreement.
As of September 27, 2025, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.  
See Note 8 — Revolving Credit Facility of the Notes to the Consolidated Condensed Financial Statements for additional information including material terms and related covenants.
ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risks associated with interest rates on our debt securities, currency movements on non-functional currency assets and liabilities, and the effect of market factors on the value of our marketable securities.  We assess these risks on a regular basis and have established policies that are designed to protect against the adverse effects of these and 
21
other potential exposures.  We use forward contracts to manage exposure to foreign currency exchange risk attributable to certain non-U.S. dollar balance sheet exposures.  Gains and losses from these foreign currency forward contracts are recognized currently in earnings along with the gains and losses resulting from remeasuring the underlying exposures.  Information about our market risks as of September 27, 2025, does not materially differ from the description of our market risks included in “
Part II – Item 7A – Quantitative and Qualitative Disclosures about Market Risk”
 within our fiscal year 2025 Annual Report on Form 10-K filed with the Commission on May 23, 2025.  For related financial statement impact see Note 5 - Derivative Financial Instruments of the Notes to the Consolidated Condensed Financial Statements.
ITEM 4.  CONTROLS AND PROCEDURES
Evaluation of disclosure controls

and procedures
As required by Rule 13a-15(b) of the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our chief executive officer (CEO) and chief financial officer (CFO), the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.  Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Commission rules and forms and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. 
Based upon the evaluation, our management, including our CEO and CFO, has concluded that our disclosure controls and procedures were effective as of September 27, 2025.
Changes in control over financial reporting
There has been no change in the Company’s internal control over financial reporting during the quarter ended September 27, 2025, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 
PART II. OTHER INFORMATION
ITEM 1.  LEGAL PROCEEDINGS
Information regarding legal proceedings to which the Company is a party is set forth in Note 13 – Legal Matters to our unaudited consolidated condensed financial statements and is incorporated herein by reference. 
ITEM 1A. RISK FACTORS
In evaluating all forward-looking statements, you should specifically consider risk factors that may cause actual results to vary from those contained in the forward-looking statements.  Various risk factors associated with our business are included in our Annual Report on Form 10-K for the year ended March 29, 2025, as filed with the Commission on May 23, 2025, and available at www.sec.gov.  Other than as set forth below, there have been no material changes to those risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended March 29, 2025.
We depend on a limited number of customers and distributors for a substantial portion of our sales, and the loss of, or a significant reduction in orders from, or pricing on products sold to, any key customer or distributor could significantly reduce our sales and our profitability.
While we generate sales from a broad base of customers worldwide, the loss of any of our key customers, or a significant reduction in sales

or selling prices

to any

key customer, or reductions in selling prices made to retain key customer relationships,

would significantly reduce our

revenue, margins and earnings and

adversely affect our business. 

For each of the

second

quarters of fiscal years 2026

and 2025, our ten largest end customers represented approximately

97 percent of our net sales.  For the first six months of fiscal years of 2026 and 2025, our ten largest end customers represented approximately 97 percent and 96 percent of our net sales, respectively.  We

had one end customer, Apple Inc., that purchased through multiple contract manufacturers and represented approximately

90 percent of the Company’s total net sales for each of the second quarters of fiscal years 2026 and 2025, and 88 percent and 89 percent for the first six months of fiscal years of 2026 and 
22
2025, respectively.

 No other end customer or distributor represented more than 10 percent of net sales for the three or six months ended September 27, 2025, or September 28, 2024. 
              We may not be able to maintain or increase sales to certain of our key customers for a variety of reasons, including:
- most of our customers can stop incorporating our products into their own products with limited notice to us and suffer little or no penalty;
- our agreements with our customers typically do not require them to purchase a minimum quantity of our products;
- many of our customers have pre-existing or concurrent relationships with our current or potential competitors that may affect the customers’ decisions to purchase our products;
- many of our customers have sufficient resources to internally develop technology solutions and semiconductor components that could replace the products that we currently supply in our customers’ end products;
- our customers face intense competition from other manufacturers that do not use our products;
- our customers may be subject to investigations and litigation that could result in injunctive or other relief that negatively impacts sales of their products, which in turn would result in a decrease in demand for our products;
- our customers regularly evaluate alternative sources of supply in order to diversify their supplier base, which increases their negotiating leverage with us and their ability to either obtain or dual-source components from other suppliers; and
- our current customers may be hesitant in some cases to award new business to us based on their desire to manage their supply chain risks around any potential over-dependence on a supplier or supply chain.   
              In addition, our dependence on a limited number of key customers may make it easier for them to demand favorable commercial terms or to pressure us on price reductions or to not accept price increases resulting from unexpected or additional cost increases or fees associated with our suppliers.  We have experienced pricing pressure from certain key customers, and we expect that the average selling prices ("ASPs") for certain of our products will decline from time to time, potentially reducing our revenue, margins, and earnings.
              Our key customer relationships often require us to develop new products that may involve significant technological challenges.  Our customers frequently place considerable pressure on us to meet tight development schedules.  In addition, we have entered, and may again enter in the future, into customer agreements providing for exclusivity periods during which we may only sell specified products or technology to a specific customer.  Even without exclusivity periods, the products that we develop are often specific to our customer's system architecture and frequently cannot be sold to other customers.  Accordingly, we have in the past and may in the future devote a substantial amount of resources to strategic relationships, which could detract from or delay our completion of other important development projects or the development of next-generation products and technologies.  Notwithstanding our efforts, our customers are not always obligated to purchase new products that we develop for them, and their failure to do so could have a material effect on our operating results, financial condition, and cash flows. 
              Our reliance on certain customers may continue to increase, which could heighten the risks associated with having key customers, including making us more vulnerable to significant reductions in revenue, margins, and earnings; pricing pressure; and other adverse effects on our business.
If we fail to attract, hire and retain qualified personnel, we may not be able to develop, market, or sell our products or successfully manage our business.
              Competition for highly qualified personnel in our industry, particularly for employees with technical backgrounds, is intense.  Some companies in our industry have adopted flexible remote work arrangements that provide more flexibility than our working arrangements, which may put us at a competitive disadvantage for talent. Accordingly, we expect competition for qualified personnel to continue to be intense because there are a limited number of individuals in the job market with the skills that we and our competitors require. 
              There also is a risk that changes in immigration laws and regulations, or their administration or enforcement, can impair our ability to attract and retain qualified engineering personnel.  In the U.S., where a significant portion of our research 
23
and development teams are located, tightening of immigration controls may adversely affect the employment status of non-U.S. engineers and other key technical employees or further impact our ability to hire new non-U.S. employees.  Moreover, certain immigration policies in the U.S. may make it more difficult for us to recruit and retain highly skilled foreign national graduates of universities in the U.S. and abroad, additionally limiting the pool of available talent. 
              The Department of Homeland Security has proposed rules to amend the H-1B registration and selection process to implement a weighted lottery system based on wage levels. Under this proposal, registrations for positions offering higher wages would be given proportionally greater chances of selection while lower wage levels would receive fewer entries. This proposed weighting system would favor higher-paid positions and could disadvantage employers, like us, seeking to hire early-career or entry-level engineers who typically qualify at lower wage levels. If implemented, this rule could further limit our access to qualified foreign technical talent and increase uncertainty in our ability to secure H-1B employees.
              There are significant costs to the Company associated with attracting and retaining qualified personnel in key technology positions.  Recruiting and employee costs, such as cash and stock-based compensation, have increased relative to historic levels and may continue to increase, which could adversely affect our results of operations.  Further, the loss of the services of key personnel or our inability to hire new personnel with the requisite skills or to assimilate talent could restrict our ability to develop new products or timely enhance existing products, sell products to our customers, or manage our business effectively.
ITEM

2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF

PROCEEDS
The following table provides information about purchases of equity securities that are registered by us pursuant to Section 12 of the Exchange Act during the three months ended September 27, 2025 (in thousands, except per share amounts):
Monthly Period
Total Number of Shares Purchased
Average Price Paid Per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
June 29, 2025 - July 26, 2025
— 
$
— 
— 
$
454,108 
July 27, 2025 - August 23, 2025
339 
$
110.05 
339 
$
416,806 
August 24, 2025 - September 27, 2025
23 
$
117.96 
23 
$
414,122 
Total
362 
$
110.55 
362 
$
414,122 
(1) As of September 27, 2025, the Company has one active share repurchase authorization, the 
$500 million in share repurchases authorized by the Board of Directors in March 2025.
  Share repurchases are to be funded from existing cash and intended to be effected from time to time in accordance with applicable securities laws through the open market, including pursuant to a Rule 10b5-1 trading plan, or in privately negotiated transactions.  The timing of repurchases and the actual amount purchased depend on a variety of factors including general market and economic conditions and other corporate considerations.  The authorization does not have an expiration date, does not obligate the Company to repurchase any particular amount of common stock, and may be modified or suspended at any time at the Company's discretion. The Company's repurchases reflected in the table above were made in the open market and were funded from existing cash.  All shares of our common stock that were repurchased were retired as of September 27, 2025.   
The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, which is included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity.  Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes.
24
ITEM 3. 

DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. 

MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. 

OTHER INFORMATION
Trading Arrangements
The following table details contracts, instructions and written plans for the purchase or sale of securities, which were entered into during the second quarter of fiscal year 
2026. 

None of our directors or Section 16 officers entered into or terminated a non-Rule 10b5-1
 trading arrangement during the second quarter of fiscal year 
2026.
Name and Title
Action
Trading Arrangement 
(1)
Date of Adoption
Expiration Date
Aggregate Number of Securities to be Purchased or Sold Pursuant to the Trading Arrangement 
(2)
Andrew Brannan
Adoption
Rule 10b5-1(c)
August 15, 2025
November 15, 2026
up to 
8,913
 to be sold
EVP, Worldwide Sales
John Forsyth
Adoption
Rule 10b5-1(c)
August 29, 2025
August 31, 2026
up to 
26,806
 to be sold
CEO
(1)
 Except as indicated by footnote, each trading arrangement marked as “Rule 10b5-1(c)” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended.
(2)
 Includes shares to be acquired upon the exercise of employee stock options.
25
ITEM 6.  EXHIBITS
The following exhibits are filed as part of or incorporated by reference into this Report:
Number
Description
3.1
Amended and Restated 
Certificate of Incorporation of Registrant, filed with the Delaware Secretary of State on July 26, 2024 (1)
3.2
Amended and Restated Bylaws of Registrant (2)
31.1
Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2
Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification of Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification of Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

1.
Incorporated by reference to Exhibit 2 to the Registrant’s Definitive Proxy Statement filed with the Commission on June 3, 2024 (Registration No. 000-17795).
2.
Incorporated by reference from Registrant’s Report on Form 8-K filed with the Commission on March 8, 2023 (Registration No. 000-17795).
*    The certifications attached as Exhibits 32.1 and 32.2 accompanying this Quarterly Report on Form 10-Q are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CIRRUS LOGIC, INC.
Date:
November 4, 2025
/s/ Jeff Woolard
Jeff Woolard
Chief Financial Officer
26